ZLDDG

ZELIRATHER DEF SET [ZLDDG]

1 day chart

About ZLDDG

Zelira Therapeutics Limited (ZLD) is a global biopharmaceutical company in the research, development and commercialisation of clinically validated cannabinoid-based medicines. Zelira owns a portfolio of proprietary revenue generating products and a pipeline of candidates undergoing clinical development positioned to enter global markets.

Buy Australian shares starting with ZLDDG. Invest today with a CHESS-sponsored investing platform!

Sector

CEO

Industry

Website

zeliratx.com

Market Capitalisation

$11M

Price-earnings ratio

-3.70

Dividend yield

0.00%

High today

$2.20

Low today

$2.00

Open price

$2.20

52-week high

52-week low

Announcements

ZLDDG FAQs

Can I buy ZLDDG shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy ZLDDG shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of ZELIRATHER DEF SET [ZLDDG]?

One share of ZELIRATHER DEF SET [ZLDDG] is valued at $2.05.

What is the ticker symbol for ZELIRATHER DEF SET [ZLDDG]?

The ticker symbol for ZELIRATHER DEF SET [ZLDDG] is ZLDDG.

How do I buy ZLDDG shares in Australia?

To buy ZLDDG stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in ZLDDG

What is the 52-week high for ZELIRATHER DEF SET [ZLDDG] stock?

The ZELIRATHER DEF SET [ZLDDG] 52-week high stock price is $NaN.

What is the 52-week low for ZELIRATHER DEF SET [ZLDDG] stock?

The ZELIRATHER DEF SET [ZLDDG] 52-week low stock price is $NaN.

What is the market capitalisation of ZELIRATHER DEF SET [ZLDDG] ZLDDG?

As of 29/09/2023 ZELIRATHER DEF SET [ZLDDG] has a market cap of $11M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.